Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra®) anti-Xa activity

被引：34

作者：

Depasse, F

Gerotziafas, GT

Busson, J

Van Dreden, P

Samama, MM

机构：

[1] LCL Clin Res Dept, Ivry, France

[2] Serbio SA Grp Stago Labs, Gennevilliers, France

[3] Hop Hotel Dieu, Serv Hematol Biol, Paris, France

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2004年 / 2卷 / 02期

关键词：

D O I：

10.1111/j.1538-7933.2004.0584a.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：346 / 348

页数：3

共 7 条

[1]

Boneu B, 1995, THROMB HAEMOSTASIS, V74, P1468

[2]

Büller HR, 2000, CIRCULATION, V102, P2726

[3] A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction - The PENTALYSE study [J].

Coussement, PK ;

Bassand, JP ;

Convens, C ;

Vrolix, M ;

Boland, J ;

Grollier, G ;

Michels, R ;

Vahanian, A ;

Vanderheyden, M ;

Rupprecht, HJ ;

Van de Werf, F .

EUROPEAN HEART JOURNAL, 2001, 22 (18) :1716-1724

[4] The pharmacokinetics of fondaparinux sodium in healthy volunteers [J].

Donat, F ;

Duret, JP ;

Santoni, A ;

Cariou, R ;

Necciari, J ;

Magnani, H ;

de Greef, R .

CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 2) :1-9

[5] Heparin pentasaccharide [J].

Gallus, AS ;

Coghlan, DW .

CURRENT OPINION IN HEMATOLOGY, 2002, 9 (05) :422-429

[6]

ICH, 1997, FED REG, V62, P27463

[7]

SAMAMAMM, 2003, THROMB RES, V109, P1

← 1 →